Pfizer Inc. (PFE)

NYSE: PFE · Real-Time Price · USD
25.58
-0.20 (-0.78%)
Jul 11, 2025, 9:41 AM - Market open
-0.78%
Market Cap 145.43B
Revenue (ttm) 62.46B
Net Income (ttm) 7.88B
Shares Out 5.69B
EPS (ttm) 1.38
PE Ratio 18.50
Forward PE 9.12
Dividend $1.72 (6.72%)
Ex-Dividend Date Jul 25, 2025
Volume 2,887,429
Open 25.63
Previous Close 25.78
Day's Range 25.46 - 25.69
52-Week Range 20.92 - 31.54
Beta 0.50
Analysts Hold
Price Target 29.92 (+16.97%)
Earnings Date Aug 5, 2025

About PFE

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr... [Read more]

Sector Healthcare
Founded 1849
Country United States
Stock Exchange NYSE
Ticker Symbol PFE
Full Company Profile

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial Statements

Analyst Summary

According to 14 analysts, the average rating for PFE stock is "Hold." The 12-month stock price target is $29.92, which is an increase of 16.97% from the latest price.

Price Target
$29.92
(16.97% upside)
Analyst Consensus: Hold
Stock Forecasts

News

3 To Watch Of 23 'Safer' July Dividends From 46 Fortune World's Most Admired Companies

I analyze the 50 Fortune World's Most Admired Companies, focusing on dividend-paying stocks and their yield-based investment potential. Three companies—Pfizer, BMW, and Singapore Airlines—currently me...

Other symbols: ACNDALFDXHDJNJKOLOW
1 day ago - Seeking Alpha

Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win

Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 vaccine infringed one of Moderna's patents, in the latest round of a long-run...

Other symbols: BNTXMRNA
1 day ago - Reuters

XTANDI® Plus Leuprolide Significantly Improves Survival Outcomes in Men with Non-Metastatic Hormone-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence

NEW YORK & TOKYO--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced positive topline results from the overall ...

1 day ago - Business Wire

Healthy Returns: Medicaid cuts in Trump's megabill may affect some drugmakers more than others

Trump's "big beautiful" bill will also affect the pharmaceutical industry, while AI startups have pulled in the majority of digital health funding this year.

Other symbols: BMYGILDJNJNVOVRTX
2 days ago - CNBC

My Top 10 High-Yield Dividend Stocks For July 2025: One Yields 12%-Plus

I present my top 10 high-yield dividend stocks for July 2025, screened for strong yields, large market caps, and attractive valuations. The list includes Chevron, Pfizer, PepsiCo, Ares Capital, BB Seg...

Other symbols: ARCCBTICVXMOMRKPEPPM
3 days ago - Seeking Alpha

Forget Get Rich Quick: The Real Dividend Strategy That Built My Income Machine

Most people either don't invest, or chase get-rich-quick schemes, which usually leads to disappointment or losses. Setting realistic, achievable financial goals based on savings rate and projected wea...

4 days ago - Seeking Alpha

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 9% (July 2025)

This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filter...

6 days ago - Seeking Alpha

Pfizer: Options Activity Speaks Bullish

The call activity above the current Pfizer Inc. share price, increasing call premiums, and the lack of defensive put buying point to options traders expecting Pfizer to move higher from current price....

7 days ago - Seeking Alpha

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

Other symbols: CVSMRK
8 days ago - Benzinga

Cannabis Lighting Market Report 2025-2030 | Share Analysis, Industry Trends & Statistics, Growth Forecasts - Pfizer Ventures into Cannabis with $6.7 Billion Deal, Boosting Industry Growth

The Cannabis Lighting Market is set to grow at a CAGR of 7.6% during the forecast period, driven by rising medical cannabis use and cultivation. Key players like Pfizer are entering the market. LED li...

9 days ago - GlobeNewsWire

House committee subpoenas Pfizer executive in probe of alleged COVID vaccine delay, CNN reports

The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an allegation that clinical testing related to the company's COVID-19 vaccine...

10 days ago - Reuters

XtalPi and Pfizer Expand Strategic Collaboration to Advance AI-Driven Drug Discovery and Materials Science Simulations

CAMBRIDGE, Mass. , June 29, 2025 /PRNewswire/ -- XtalPi (2228.HK), a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaki...

11 days ago - PRNewsWire

Pfizer's bleeding disorder therapy meets main goal in patients with certain antibodies

Pfizer said on Thursday its hemophilia therapy, Hympavzi, met the main goal of a late-stage study in patients with certain types of antibodies.

15 days ago - Reuters

Pfizer Announces Positive Topline Phase 3 Results for HYMPAVZI™ in Hemophilia A or B with Inhibitors

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 BASIS study (NCT03938792) evaluating HYMPAVZI™ (marstacimab) for adults and adolescents liv...

15 days ago - Business Wire

Pfizer Could Be The Turnaround Story In The Pharmaceutical Space

Pfizer's post-pandemic revenue decline is temporary; new launches like Abrysvo and Adcetris, plus Seagen integration, position it for a 2025 turnaround. Valuation is compelling: Pfizer trades at deep ...

15 days ago - Seeking Alpha

Pfizer Declares Third-Quarter 2025 Dividend

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.43 third-quarter 2025 dividend on the company's common stock, payable September 2, 2025, to...

15 days ago - Business Wire

Don't Sleep On Pfizer: The Turnaround Is Just Getting Started

Despite a revenue miss, Pfizer's Q1 earnings crushed estimates due to aggressive, structural cost-cutting, signaling a powerful shift towards operational and margin excellence. Management is expanding...

15 days ago - Seeking Alpha

17 Ideal 'Safer' Dividend Dogs To Buy Out Of 72 June Graham Value All-Stars

I use YCharts' Value Score and Ben Graham Formula Value All Stars, or GASV, to identify large-cap stocks offering strong value and dividend safety. Seventeen out of twenty-four "safer" lowest-priced D...

15 days ago - Seeking Alpha

Top stock price forecast: Plug Power, Uber, and Pfizer

The US stock market bounced back on Tuesday after the truce between Iran and Israel. The Dow Jones, Nasdaq 100, and S&P 500 indices jumped by over 1%, and the bullish momentum continued in the futures...

Other symbols: PLUGUBER
15 days ago - Invezz

Pfizer Invites Public to View and Listen to Webcast of August 5 Conference Call with Analysts

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:00 a.m. EDT on Tuesday, ...

15 days ago - Business Wire

10 'Safer' Dividend Buys Of Barron's Better Bets Than T-Bills For June

Long-term bond yields continue to rise. But investors looking for income can still find plenty of attractive opportunities with dividend-paying stocks that have healthy yields. “23 stocks pay huge div...

Other symbols: BBYBMYCAGEQRETRFRTKEY
16 days ago - Seeking Alpha

Pharma companies need to beef up M&A right now, says Mizuho's Jared Holz

Jared Holxz, Mizuho, joins 'Fast Money' to talk competition in the obesity drug space.

17 days ago - CNBC Television

The Dark Side Of Dividend Growth Investing

Dividend growth investing is a powerful way to compound wealth and set yourself up for financial independence. However, it also has some real drawbacks. I share 3 aspects of the dark side of dividend ...

Other symbols: ETLEGOTWBAWPCXIFR
20 days ago - Seeking Alpha

I'm Buying Dividend Giants At Huge Discounts

Now is a great time to be an income and value investor, particularly in the energy and pharmaceutical spaces. I highlight 2 undervalued names that provide well-covered dividends with a strong growth o...

21 days ago - Seeking Alpha

Will Pfizer Slash Its >7% Yielding Dividend? I Wouldn't Rule It Out

Pfizer's >7% dividend yield is attractive, but faces significant risk due to political, regulatory, and business headwinds impacting revenue and profitability. Major threats include U.S. healthcare po...

21 days ago - Seeking Alpha